Parameter | Group I | Group II | P value |
---|---|---|---|
Pathological stage | |||
T1 | 21 (7.7%) | 39 (13.7%) | 0.042 |
T2 | 42 (15.4%) | 101 (35.6%) | 0.0001 |
T3 | 118 (43.2%) | 116 (40.8%) | 0.775 |
T4 | 92 (33.7%) | 28 (9.9%) | 0.0001 |
N stage | |||
N0 | 86 (31.5%) | 91 (32.0%) | 0.931 |
N1 | 68 (24.9%) | 87 (30.6%) | 0.276 |
N2 | 92 (33.7%) | 73 (25.7%) | 0.133 |
N3 | 27 (9.9%) | 33 (11.6%) | 0.589 |
TNM Stage | |||
IA | 18 (6.6%) | 30 (10.6%) | 0.135 |
IB | 30 (11.0%) | 47 (16.5%) | 0.114 |
IIA | 43 (15.8%) | 61 (21.5%) | 0.165 |
IIB | 51 (18.7%) | 47 (16.5%) | 0.586 |
IIIA | 58 (21.2%) | 65 (22.9%) | 0.765 |
IIIB | 51 (18.7%) | 24 (8.5%) | 0.002 |
IIIC | 22 (8.1%) | 10 (3.5%) | 0.044 |